Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index; 45 of the 212 sources its claims cite were checked for support.
Abstract
Bone tissue is continuously remodeled through the concerted actions of bone cells, which include bone resorption by osteoclasts and bone formation by osteoblasts, whereas osteocytes act as mechanosensors and orchestrators of the bone remodeling process. This process is under the control of local (e.g., growth factors and cytokines) and systemic (e.g., calcitonin and estrogens) factors that all together contribute for bone homeostasis. An imbalance between bone resorption and formation can result in bone diseases including osteoporosis. Recently, it has been recognized that, during bone remodeling, there are an intricate communication among bone cells. For instance, the coupling from bone resorption to bone formation is achieved by interaction between osteoclasts and osteoblasts. Moreover, osteocytes produce factors that influence osteoblast and osteoclast activities, whereas osteocyte apoptosis is followed by osteoclastic bone resorption. The increasing knowledge about the structure and functions of bone cells contributed to a better understanding of bone biology. It has been suggested that there is a complex communication between bone cells and other organs, indicating the dynamic nature of bone tissue. In this review, we discuss the current data about the structure and functions of bone cells and the factors that influence bone remodeling.
Overview
CoChat Summary
TL;DR
This narrative review summarizes bone tissue biology, focusing on the structure and functions of osteoblasts, bone lining cells, osteocytes, and osteoclasts, the extracellular matrix, and local/systemic regulators of bone remodeling. It emphasizes cell–cell coupling, osteocyte mechanosensing, estrogen’s role, and emerging endocrine functions of bone.
Key findings
- Bone contains four cell types: osteoblasts (4–6% of total resident bone cells) form bone; osteocytes (90–95% of total bone cells, lifespan up to 25 years) act as mechanosensors and orchestrators; osteoclasts resorb bone; bone lining cells participate in coupling and the basic multicellular unit.
- The osteocyte lacunocanalicular system includes up to 50 cytoplasmic processes per cell; osteocyte surface is estimated to be 400-fold larger than all Haversian and Volkmann systems and more than 100-fold larger than trabecular bone surface; the lacunar space is about 0.5–1.0 μm wide and the canalicular membrane distance is 50–100 nm.
- Bone remodeling proceeds through initiation of resorption, a transition/reversal phase, and bone formation; coupling involves matrix-released factors such as IGFs, TGF-β, BMPs, FGF, and PDGF, plus semaphorins (Sema4D, Sema3A) and ephrinB2/EphB4, while imbalance can cause osteoporosis or osteopetrosis.
- Estrogen maintains bone homeostasis by inhibiting osteoblast and osteocyte apoptosis, suppressing osteoclast formation/activity, inducing osteoclast apoptosis, and modulating RANKL/OPG and cytokines; bone endocrine actions include undercarboxylated osteocalcin effects on pancreas, adipose tissue, testis, and brain, and osteocyte FGF23 regulation of phosphate metabolism.
Methods
- Design: narrative review; the authors state they discuss current data about bone cells, bone matrix, factors influencing bone remodeling, and estrogen under physiological and pathological conditions.
- Data or sample: no primary sample or dataset; evidence is drawn from cited in vitro and in vivo studies and prior literature.
- Main analysis: narrative synthesis of structural, molecular, and functional findings; no systematic search, meta-analysis, or new experiments are reported.
Limitations
- Stated in the paper: bone lining cell functions are not completely understood; mechanisms of osteocyte mechanosensing and the precise osteocyte-derived osteoclastogenesis-stimulating factors remain uncertain; direct in vivo contact between mature osteoblasts and osteoclasts has not been demonstrated and is controversial; bone endocrine function is still poorly understood.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, risk-of-bias assessment, or quantitative synthesis, and its conclusions depend on the selected cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
23 Valid · 2 Not valid · 92 Not checked · 16 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For instance, in bones subjected to fatigue loading, viable osteocytes near the apoptotic ones express, besides high RANKL/OPG ratio, increased levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (CCL2) promoting an increase in local osteoclastogenesis [194, 195].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.8. Bone Remodeling Process
What the sources say
- Partly supportedcites [194] matched to “Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations” (2012) sourceExperimental — accuracy not yet measured
Kennedy et al. (2012) support most of the sentence: the Abstract (p.1) and Results > Immunohistochemistry show RANKL and VEGF staining peaking 100-300 um from the damage site in non-apoptotic osteocytes while caspase-3+ cells dominate the damage core, and the Discussion states the RANKL/OPG ratio shift 'favoring osteoclast formation'. However, the candidate genes and IHC targets were only RANKL, OPG, VEGF and M-CSF (Materials and Methods > Gene expression analyses; Results > Gene expression) - CCL2/MCP-1 is neither measured nor mentioned anywhere in our copy (searched: CCL2, monocyte chemoattractant protein-1, MCP-1, chemokine), so that part of the claim is not attributable to this source. Also, the pro-osteoclastogenic conclusion is inferred from signaling patterns, since tissues were analyzed 3 and 7 days after fatigue, 'prior to the first appearance of osteoclasts'. (LLM, conf=0.85)
- Disputedcites [195] matched to “MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling” (2013) sourceExperimental — accuracy not yet measured
Our copy places CCL2/MCP-1 expression in osteoblasts, not osteocytes: the Abstract reports that by in-situ hybridization and immunohistochemistry 'MCP-1 mRNA and protein was localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point, but not within osteocytes adjacent to the SFx', and the Discussion likewise concludes MCP-1 is secreted by osteoblasts as a candidate signal attracting osteoclasts and their precursors. The paper's model is rat ulnar stress fracture initiation by cyclic end-loading, and it explicitly contrasts this with 'adaptive' ulnar loading; nowhere does our copy report viable osteocytes near apoptotic ones, nor any measurement of VEGF or of a high RANKL/OPG ratio in osteocytes (RANKL/OPG appears only as a downstream pathway shared with gp-130 cytokines such as IL-6/IL-11, Discussion). Thus the cellular source and the VEGF/RANKL-OPG components attributed to this source are contrary to, or absent from, our copy. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Bone lining cells functions are not completely understood, but it has been shown that these cells prevent the direct interaction between osteoclasts and bone matrix, when bone resorption should not occur, and also participate in osteoclast differentiation, producing osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa-B ligand (RANKL) [14, 53].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.2. Bone Lining Cells
What the sources say
- Could not verifycites [14] matched to “A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone” (2009) sourceExperimental — accuracy not yet measured
The Discussion describes bone-lining cells as poorly characterized and suggests they may be early osteoblast-lineage cells. It separately suggests that osteoblast precursors near differentiating pre-osteoclasts may express RANKL, but does not identify those precursors as bone-lining cells or say that bone-lining cells produce OPG. Searches for bone-lining cells with OPG, RANKL, and osteoclast differentiation found no passage establishing the claim. (LLM, conf=0.73)
- Not checked yetcites [53] 2000, Journal of Rehabilitation Research and Development
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, osteocyte apoptosis has been recognized as a chemotactic signal to osteoclastic bone resorption [70–73].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.3. Osteocytes
What the sources say
- Not checked yetcites [70] matched to “Identification of apoptotic changes in osteocytes in normal and pathological human bone” (1997) source
- Not checked yetcites [71] matched to “Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.” (2006) source
- Supportedcites [72] matched to “Apoptotic Osteocytes and the Control of Targeted Bone Resorption” (2014) source
The section on osteocyte apoptosis and osteoclast recruitment states that apoptotic osteocytes recruit osteoclasts to initiate bone resorption. It also identifies HMGB1, released by apoptotic osteocytic cells, as chemotactic for osteoclasts, while noting that the signals responsible in vivo remain to be identified. (LLM, conf=0.86)
- Supportedcites [73] matched to “Osteocyte-Driven Bone Remodeling” (2014) source
In section 3, “Dying osteocytes,” the review says apoptotic osteocytes precede resorption and may act as beacons for osteoclast recruitment. It also describes a potential chemotactic factor released during osteocyte apoptosis. The claim reflects that proposed link without identifying a specific signal. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other recent evidence is that osteoclasts may also directly regulate the hematopoietic stem cell niche [112].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.4. Osteoclasts
What the sources say
- Supportedcites [112] matched to “Osteoclasts: more than ‘bone eaters’” (2014) source
The HSC-niche section says osteoclasts may directly regulate the hematopoietic stem cell niche. The Concluding Remarks repeat this qualified claim while noting that conflicting reports remain to be resolved. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.7. Local and Systemic Factor That Regulate Bone Homeostasis
What the sources say
- Partly supportedcites [16] matched to “Estrogen and the skeleton” (2012) sourceExperimental — accuracy not yet measured
Our copy supports only the sex-steroid part of the attributed list: the Overview of estrogen action on bone states that 'estrogen is perhaps the major systemic regulator of bone metabolism not only in women, but also in men,' and the same section (citing Falahati-Nini et al., ref 5) and ref 31 address androgens/testosterone as systemic bone regulators. The other four factors named in the claim — parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol) and glucocorticoids — appear nowhere in our copy (searched: 'systemic factors parathyroid hormone calcitonin 1,25-dihydroxyvitamin D glucocorticoids', 'parathyroid hormone', 'calcitonin', 'glucocorticoids calcitonin vitamin D androgens'); every returned passage concerned estrogen actions, coupling factors in the bone remodeling compartment, or the reference list. Thus the paper does not enumerate the systemic hormonal repertoire the citing sentence attributes to it. (LLM, conf=0.72)
- Partly supportedcites [147] matched to “Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone” (2001) sourceExperimental — accuracy not yet measured
The Introduction (p. 1) of Calvi et al. 2001 supports only the PTH element of the list: it describes PTH as 'a major regulator of calcium homeostasis' that 'plays an important role in both bone formation and resorption' in the context of factors controlling osteoblast/osteoclast balance. Our copy nowhere mentions calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, or estrogens as systemic factors maintaining bone homeostasis (searched: calcitonin; estrogen/glucocorticoid/systemic hormonal regulators; 1,25-dihydroxyvitamin D3), so the remaining five items attributed to this source are unsupported. The paper's scope is the local action of activated PTH/PTHrP receptor in osteoblastic cells on cortical versus trabecular bone in transgenic mice, not a survey of systemic hormonal regulators. (LLM, conf=0.72)
- Not checked yetcites [148] 2002, BMC Musculoskeletal Disorders
- Not checked yetcites [149] matched to “Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS” (2002) source
- Not checked yetcites [150] matched to “Androgens and Bone” (2004) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 12 with their cited sources checked
Create a free account to see all 133 claims and to verify the 167 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, a set of osteoblasts, all with similar morphologies, lay down osteoid on active bone-forming surfaces.268”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [268]
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246 · cited 2×
“The expressions of Runtrelated transcription factors 2,Distal-less homeobox 5 (Dlx5), and osterix (Osx) are crucial for osteoblast differentiation [22, 26].”
BackgroundKomori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 3×
“Besides osteoclasts and osteoblasts, it has been demonstrated that osteocytes play key roles during the bone remodeling cycle [8].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 2×
“Together, these factors promote the activation of transcription factors [81, 82] and gene expression in osteoclasts [83, 84].”
BackgroundFunctions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“On the other hand, another factor called osteoprotegerin (OPG), which is produced by a wide range of cells including osteoblasts, stromal cells, and gingival and periodontal fibroblasts [87–89], binds to RANKL, preventing the RANK/RANKL interaction and, consequently, inhibiting the osteoclastogenesis [87] (Figure 5).”
Background
Research works printed but not linked: 15
- 2004, Histology and Histopathology, 19, 1325
- 1998, The nature of the mineral phase in bone, 23
- 1990, Bone-forming cells in clinical conditions, 351
- 1989, Scanning Microscopy, 3, 953
- 2000, Journal of Rehabilitation Research and Development, 37, 189
- 1999, The FASEB Journal, 13, S101
- 1999, Laboratory Investigation, 79, 83
- 2008, Journal of Musculoskeletal Neuronal Interactions, 8, 204
- 2005, Journal of Musculoskeletal Neuronal Interactions, 5, article 316
- 1972, Bone resorption and matrix hexosamine labeling, 327
- 2008, Integrins and adhesion molecules, 385
- 2004, Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 505
- 2002, BMC Musculoskeletal Disorders, 7, 3
- 1997, Endocrine Society Journals and Publications, 82, 3128
- 2006, Journal of Musculoskeletal Neuronal Interactions, 6, 354
Cited by
Items 701–800 of 1,003
Kang, N., Kim, K. W., & Shin, D. M. (2019) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2019.23.5.411 · Cited by 19
Khotib, J., Lasandara, C. S. A., Samirah, S., & Budiatin, A. S. (2019) · Folia Medica Indonesiana · doi:10.20473/fmi.v55i3.15495 · Cited by 19
Muszyńska, M., Ambrożewicz, E., Gęgotek, A., Grynkiewicz, G., & Skrzydlewska, E. (2020) · Molecules · doi:10.3390/molecules25081990 · Cited by 19
Chakrabarti, S., Ren, J., & Wu, J. (2020) · Nutrients · doi:10.3390/nu12102998 · Cited by 19
Bastos, A. R., Maia, F. R., Oliveira, J. M., Reis, R. L., & Correlo, V. M. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112413 · Cited by 19
Liquid biopsies in primary and secondary bone cancers
Ucci, A., Rucci, N., & Ponzetti, M. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.17 · Cited by 19
Optimal cell traction forces in a generalized motor-clutch model
Alonso‐Matilla, R., Provenzano, P. P., & Odde, D. J. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.07.012 · Cited by 19
Bone and Soft Tissue Turnover in Relation to All-cause Mortality in Postmenopausal Women
Bager, C. L., Willumsen, N., Christiansen, C., Bay‐Jensen, A., Nielsen, H. B., & Karsdal, M. A. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly163 · Cited by 19
Fibrous heart valve leaflet substrate with native-mimicked morphology
Jana, S., Franchi, F., & Lerman, A. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101112 · Cited by 19
The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment
Sattari, M., Taheri, R. A., Arefnezhad, R., & Motedayyen, H. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01883-8 · Cited by 19
Taatjes, D. J., & Roth, J. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1541-0 · Cited by 19
Investigation of bone toxicity in drug development: review of current and emerging technologies
Tuladhar, A., Guffroy, M., Finnema, S. J., Christmann, R., Vleet, T. R. V., Mayana, S. A. K., & Fossey, S. L. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf131 · Cited by 18
Michalak, F., Hnitecka, S., Dominiak, M., & Grzech‐Leśniak, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030354 · Cited by 18
Increased Material Density within a New Biomechanism
Andreucci, C. A., Fonseca, E. M. M., & Jorge, R. N. (2022) · Mathematical and Computational Applications · doi:10.3390/mca27060090 · Cited by 18
Impact of 1,25-dihydroxyvitamin D3 PLGA-nanoparticles/chitosan hydrogel on osteoimmunomodulation
Gao, R., Xu, S., Chen, C., Liu, D., He, Y., Zang, Y., Dong, X., Ma, G., & Liu, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125624 · Cited by 18
Bibliometric and visualized analysis of 3D printing bioink in bone tissue engineering
Xu, K., Yu, S., Wang, Z., Zhang, Z., & Zhang, Z. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1232427 · Cited by 18
Lopes, C. S., Delfino, M. M., Tanomaru‐Filho, M., Sasso‐Cerri, E., Guerreiro‐Tanomaru, J. M., & Cerri, P. S. (2024) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-024-06781-3 · Cited by 18
Self-citationTrends in bioactivity: inducing and detecting mineralization of regenerative polymeric scaffolds
Nitschke, B. M., Beltran, F. O., Hahn, M. S., & Grunlan, M. A. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02674d · Cited by 18
Luo, P. F., Zhang, Y., Huang, M., Luo, G., Ma, Y., & Wang, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s443413 · Cited by 18
Sensing the future: A review on emerging technologies for assessing and monitoring bone health
Naik, A., Kale, A., & Rajwade, J. M. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214008 · Cited by 18
Ma, J., Li, X., Li, Q., Sun, Z., You, Y., Zhang, L., Ji, Z., Zhou, H., Zhang, Q., Wang, L., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117447 · Cited by 18
Yekani, M., Dizaj, S. M., Sharifi, S., Sedaghat, H., Saffari, M., & Memar, M. Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38392 · Cited by 18
Strontium-Doped Whitlockite Scaffolds for Enhanced Bone Regeneration
Hennebert, P. M., Amirthalingam, S., Kang, T. H., So, K., & Hwang, N. S.-Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c13391 · Cited by 18
Bone regenerative medicine: An emerging field with opportunities and challenges
Sadat‐Shojai, M., Asadnia, M., Shahsavani, M. B., & Yousefi, M. M. (2025) · Journal of the American Ceramic Society · doi:10.1111/jace.20508 · Cited by 18
A single-cell atlas of the murine limb skeleton integrating the developmental and adult stages
Herpelinck, T., Ory, L., Verbraeken, T., Nasello, G., Barzegari, M., Bolander, J., Luyten, F. P., Tylżanowski, P., & Geris, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-05277-6 · Cited by 18
Mansoorifar, A., Subbiah, R., Balbinot, G. D. S., Parthiban, S. P., & Bertassoni, L. E. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107636 · Cited by 18
Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats
Zhang, R., Yang, M., Li, Y., Liu, H., Ren, M., & Tao, Z.-S. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-02151-1 · Cited by 18
Shao, R., Dong, Y., Zhang, S., Wu, X., Huang, X., Sun, B., Zeng, B., Xu, F., & Liang, W. (2022) · Biotechnology Journal · doi:10.1002/biot.202100074 · Cited by 18
Up-to-date progress in bioprinting of bone tissue
Wu, Y. B., Li, M., Su, H., Chen, H., & Zhu, Y. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v9i1.628 · Cited by 18
Triawanti, T., Yunanto, A., Sanyoto, D. D., & Nur’amin, H. W. (2018) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.6.1.14 · Cited by 18
Schoenmaker, T., Wouters, F., Micha, D., Forouzanfar, T., Netelenbos, J. C., Eekhoff, E. M. W., Bravenboer, N., & de Vries, T. J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27693 · Cited by 18
Pomini, K. T., Cestari, T. M., German, Í. J. S., Rosso, M. P. D. O., Gonçalves, J. B. D. O., Buchaim, D. V., Pereira, M., Andreo, J. C., Rosa, G. M., Coletta, B. B. D., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.12.031 · Cited by 18
Gong, Y. S., Li, S., Zeng, W. G., Yu, J., Chen, Y., & Yu, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00413 · Cited by 18
Optoacoustic Tissue Differentiation Using a Mach–Zehnder Interferometer
Kenhagho, H. N., Rauter, G., Guzman, R. G., Cattin, P. C., & Zam, A. (2019) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2019.2923696 · Cited by 18
Vdr expression in osteoclast precursors is not critical in bone homeostasis
Verlinden, L., Janssens, I., Doms, S., Vanhevel, J., Carmeliet, G., & Verstuyf, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105478 · Cited by 18
CUEDC2 controls osteoblast differentiation and bone formation via SOCS3–STAT3 pathway
Kim, J.-W., Oh, S., Lee, M. N., Song, J. H., Jeong, B., Yang, J.-W., Piao, X., Zang, Y., Ryu, J., & Koh, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2562-5 · Cited by 18
Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
Lappin, K. M., Mills, K., & Lappin, T. R. J. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0387 · Cited by 18
Integrating Additive and Traditional Manufacturing for Multiscale Bone Tissue Engineering Scaffolds
Zhu, Y., Gao, H., Qiao, Q., Yuan, Y., Fang, D., Bai, Y., & Jiang, Q. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16090349 · Cited by 17
Immune-Guided Bone Healing: The Role of Osteoimmunity in Tissue Engineering Approaches
Munaò, S., Armeli, A., Bonfiglio, D., Iaconis, A., & Calabrese, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311642 · Cited by 17
Disorders of Mineral Metabolism: Normal Homeostasis
Root, A. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00009-9 · Cited by 17
Xu, C., Jin, S., Jin, C., Dai, Z.-H., Wu, Y., He, G.-L., Ma, H., Xu, C.-Y., & Fang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109893 · Cited by 17
Sari, D. S., Pujiastuti, P., Fatmawati, D. W. A., Mardiyana, M. A., Wulandari, A. T., & Arina, Y. M. D. (2023) · The Saudi Dental Journal · doi:10.1016/j.sdentj.2023.03.007 · Cited by 17
Spheroids as a 3D in vitro model to study bone and bone mineralization
Boscaro, D., & Sikorski, P. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213727 · Cited by 17
Functionalized hydrogels as smart gene delivery systems to treat musculoskeletal disorders
Enayati, M. S., Liu, W., Madry, H., Neisiany, R. E., & Cucchiarini, M. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103232 · Cited by 17
Osteogenic Differentiation of Human Gingival Fibroblasts Inhibits Osteoclast Formation
Ceylan, M., Schoenmaker, T., Hogervorst, J. M. A., Jansen, I. D. C., Schimmel, I. M., Prins, C., Laine, M. L., & de Vries, T. J. (2024) · Cells · doi:10.3390/cells13131090 · Cited by 17
German, Í. J. S., Barbalho, S. M., Andreo, J. C., Zutin, T. L. M., Laurindo, L. F., Rodrigues, V. D., Araújo, A. C., Guiguer, É. L., Direito, R., Pomini, K. T., et al. (2024) · Metabolites · doi:10.3390/metabo14100560 · Cited by 17
Heinämäki, J., Коshovyi, O., Botsula, I., Shpychak, A. O., Vo, H. Q., Nguyen, H. T., & Raal, A. (2025) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/term/2812191 · Cited by 17
Osteoporosis following heart transplantation and immunosuppressive therapy
Löfdahl, E., & Rådegran, G. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.08.002 · Cited by 17
Mineralization of Bones in Osteoporosis and Osteomalacia
Elbossaty, W. F. (2017) · Annals of Clinical and Laboratory Research · doi:10.21767/2386-5180.1000201 · Cited by 17
Gao, L., Gong, F., Ma, L., & Yang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10312 · Cited by 17
Avian bone physiology and poultry bone disorders
Rath, N. C., & Durairaj, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819770-7.00037-2 · Cited by 17
Advent of phytobiologics and nano-interventions for bone remodeling: a comprehensive review
Gupta, A., Mehta, S. K., Kumar, A., & Singh, S. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.2010031 · Cited by 17
Micro-RNA: A Future Approach to Personalized Diagnosis of Bone Diseases
Lombardi, G., & DELVIN, E. E. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00959-z · Cited by 17
A brief review of mRNA therapeutics and delivery for bone tissue engineering
Rajendran, A. K., Amirthalingam, S., & Hwang, N. S.-Y. (2022) · RSC Advances · doi:10.1039/d2ra00713d · Cited by 17
Foxf2 represses bone formation via Wnt2b/β-catenin signaling
Tanaka, T. N., Takahashi, A., Kobayashi, Y., Saito, M., Xiaolong, S., Jingquan, C., Ito, Y., Kato, T., Ochi, H., Sato, S., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00779-z · Cited by 17
Murugesan, V., Vaiyapuri, M., & Murugeasan, A. (2022) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2022.109653 · Cited by 17
Komrakova, M., Büchler, G., Böker, K. O., Lehmann, W., Schilling, A. F., Roch, P. J., Taudien, S., Hoffmann, D. B., & Sehmisch, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01865-9 · Cited by 17
Bone Sialoprotein Immobilized in Collagen Type I Enhances Bone Regeneration In vitro and In vivo
Kriegel, A., Schlosser, C., Habeck, T., Dahmen, C., Götz, H., Clauder, F., Armbruster, F. P., Baranowski, A., Drees, P., Rommens, P. M., et al. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i3.591 · Cited by 17
Nazari, S., Naeimi, M., Rafienia, M., & Monajjemi, M. (2023) · Journal of Polymers and the Environment · doi:10.1007/s10924-023-02966-z · Cited by 17
Does transcription-associated DNA damage limit lifespan?
Callegari, A. J. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.03.001 · Cited by 17
Mandakhbayar, N., El‐Fiqi, A., Dashnyam, K., & Kim, H. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00810 · Cited by 17
Osorio, Z. V., Álvarez, A. L., Piñeiro, Y., Vázquez‐Vázquez, C., Gómez-Amoza, J. L., Blanco-Méndez, J., Otero-Espinar, F. J., & Rivas, J. M. (2019) · ACS Omega · doi:10.1021/acsomega.8b03676 · Cited by 17
Mounier, L., Morel, A., Ferrandez, Y., Morko, J. P., Vääräniemi, J., Gilardone, M., Roche, D., Cherfils, J., & Blangy, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01201 · Cited by 17
Bagherifard, A., Hemmatyar, A., Khosravi, K., Rouzbahani, A., Mokhtari, K., Yahyazedeh, H., & Tanzadehpanah, H. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01907-1 · Cited by 16
Biomaterial-assisted gene therapy for bone repair
Yang, L., Li, W., Yu, Y., Wang, H., & Wang, X. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102886 · Cited by 16
Advanced silk materials for musculoskeletal tissue regeneration
Nie, K., Zhou, S., Li, H., Tian, J., Shen, W., & Huang, W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1199507 · Cited by 16
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
Mebarek, S., Skafi, N., & Brizuela, L. (2023) · Cancers · doi:10.3390/cancers15102732 · Cited by 16
D’Andrea, L., Gastaldi, D., Baino, F., Verné, E., Schwentenwein, M., Örlygsson, G., & Vena, P. (2023) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.3795 · Cited by 16
Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulation
Shang, Y., Zhu, Q., Ding, J., Zhao, L., Zhang, F., Lu, J., Feng, Y., Wang, J., Liu, Z., Kuang, M., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.048 · Cited by 16
The Role of Aryl Hydrocarbon Receptor in Bone Biology
Vyavahare, S. S., Ahluwalia, P. K., Gupta, S. K., Kolhe, R. B., Hill, W., Hamrick, M. W., Isales, C. M., & Fulzele, S. (2024) · International Journal of Tryptophan Research · doi:10.1177/11786469241246674 · Cited by 16
Bone: A Neglected Endocrine Organ?
Szeliga, A., Grymowicz, M., Kostrzak, A., Smolarczyk, R., Bala, G., Smolarczyk, K., Męczekalski, B., & Suchta, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133889 · Cited by 16
Calcium and vitamin D: roles, interactions and nutritional programming for bone development
Zastulka, A., Clichici, S. V., Culic, B., Pop, N.-L., Olteanu, C.-D., Delcea, C., Sabău, L. I., & Mocan, T. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.747 · Cited by 16
Ai, H., Dou, C., Wu, Y., Zhang, D., Zhang, Z., Zhang, C., Xi, Y., Qu, Y., Tan, J., Yin, P., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.01.004 · Cited by 16
Srinivasan, S., Vijayalekha, A., Anandasadagopan, S. K., & Pandurangan, A. K. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00408-z · Cited by 16
Rašeta, M., Kebert, M., Pintać, D., Mišković, J., Berežni, S., Kulmány, Á. E., Zupkó, I., Karaman, M. A., & Jovanović-Šanta, S. (2025) · Microorganisms · doi:10.3390/microorganisms13061210 · Cited by 16
Calcium Phosphate Biomaterials for Bone Tissue Engineering: Properties and Relevance in Bone Repair
Maji, K., & Mondal, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-34471-9_20 · Cited by 16
Emerging roles for myeloid immune cells in bone metastasis
Alsamraae, M., & Cook, L. M. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09965-3 · Cited by 16
Liu, L., Mu, H., & Pang, Y. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_186_20 · Cited by 16
Hu, S., Meng, Z., Zhou, J., Li, Y., Su, Y., Lei, Q., Mao, M., Qu, X., He, J., & Wang, W. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i2.514 · Cited by 16
Rajabi, M., Cabral, J. D., Saunderson, S. C., & Ali, M. A. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119884 · Cited by 16
Dentin Particulate for Bone Regeneration: An In Vitro Study
Brunello, G., Zanotti, F., Scortecci, G. M., Sapoznikov, L., Sivolella, S., & Zavan, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169283 · Cited by 16
Sun, P., Antwi, S. O., Sartorius, K., Zheng, X., & Li, X. (2022) · Cancers · doi:10.3390/cancers14194888 · Cited by 16
Chang, A., Lin, L., Chen, Y.-C., Chen, P., Liu, S., Tai, H., Wu, H., Sung, S.-Y., Lin, T., & Tang, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.77495 · Cited by 16
Shaz, N., Maran, S., Genasan, K., Choudhary, R., Alias, R., Swamiappan, S., Kamarul, T., & Raghavendran, H. R. B. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128059 · Cited by 16
der Heide, D. V., Hatt, L. P., Bella, E. D., Hangartner, A., Lackington, W. A., Yuan, H., Groot, F. B., Stoddart, M. J., & D’Este, M. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100518 · Cited by 17
Ribeiro, D. C., Pereira, A. D., de Santana, F. C., Mancini‐Filho, J., da Silva, E. M., da Costa, C. A. S., & Boaventura, G. T. (2017) · Lipids · doi:10.1007/s11745-017-4245-2 · Cited by 16
Transdifferentiation of myoblasts into osteoblasts – possible use for bone therapy
Lin, D., Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12790 · Cited by 16
Richbourg, H. A., Mitchell, C. F., Gillett, A. N., & McNulty, M. A. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1423-2 · Cited by 16
Repercussion of nonsteroidal anti-inflammatory drugs on the gene expression of human osteoblasts
Melguizo‐Rodríguez, L., Costela-Ruiz, V. J., Manzano‐Moreno, F. J., Montes, R. I., Ramos‐Torrecillas, J., García‐Martínez, O., & Ruíz, C. (2018) · PeerJ · doi:10.7717/peerj.5415 · Cited by 16
Diamanti‐Kandarakis, E., Duntas, L. H., Kanakis, G., Kandaraki, E., Karavitaki, N., Kassi, E. N., Livadas, S., Mastorakos, G. P., Migdalis, I. N., Miras, A. D., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0154 · Cited by 16
Isolated Compounds from Turpinia formosana Nakai Induce Ossification
Imtiyaz, Z., Wang, Y.-F., Lin, Y.-T., Liu, H., & Lee, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133119 · Cited by 16
Khalaf, O. H., Chaki, S. P., Garcia-Gonzalez, D. G., Suva, L. J., Gaddy, D., & Arenas-Gamboa, Á. M. (2020) · Infection and Immunity · doi:10.1128/iai.00822-19 · Cited by 16
Tilkin, R. G., Régibeau, N., Lambert, S., & Grandfils, C. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00214 · Cited by 16
Bourebaba, L., Michalak, I., Baouche, M., Kucharczyk, K., Fal, A., & Marycz, K. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15294 · Cited by 16
Drug Delivery Based on Nanotechnology for Target Bone Disease
Yang, X., Chen, S., Liu, X., Yu, M., & Liu, X. (2019) · Current Drug Delivery · doi:10.2174/1567201816666190917123948 · Cited by 15
Ling, Q., Li, H., Zhao, J., Guo, W., Yu, H., Li, Z. Y., Hu, Y., Wei, S., Fu, Y., Zhang, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69004-z · Cited by 15
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis
Poorirani, S., Taheri, S. L., & Mostafavi, S. A. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06543-3 · Cited by 15
Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements
da Costa, N. D. S., Lima, L. S., Galiciolli, M. E. A., Ribeiro, D. H. F., Ribeiro, M. M., Garica, G. D. P. J., Marçal, I. S., da Silva, J. F., Pereira, M. E., Oliveira, C. S., et al. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127446 · Cited by 15
Biofabrication Approaches for Peri-Implantitis Tissue Regeneration: A Focus on Bioprinting Methods
Shopova, D., Mihaylova, A., Yaneva, A., Bakova, D. R., & Dimova-Gabrovska, М. (2024) · Prosthesis · doi:10.3390/prosthesis6020028 · Cited by 15
3D printed biopolymer/black phosphorus nanoscaffolds for bone implants: A review
Wu, N., Li, J., Li, X., Wang, R., Zhang, L., Liu, Z., & Jiao, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135227 · Cited by 15
Metadata
- Authors
- Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S.
- Affiliations
- Department of Morphology and Genetics, Laboratory of Histology and Structural Biology, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
- Universidade Federal de São Paulo (BR)
- Department of Morphology, Laboratory of Histology and Embryology, Dental School, Universidade Estadual Paulista (UNESP), 14801-903 Araraquara, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Cerri, Paulo Sérgio
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4515490
- OpenAlex
- W1594526962
- Cited by
- 2,044
- References
- 209
- Citations by year
- 2026: 157 · 2025: 238 · 2024: 265 · 2023: 286 · 2022: 254 · 2021: 241 · 2020: 219 · 2019: 169 · 2018: 110 · 2017: 64 · 2016: 35 · 2015: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- bone remodeling, bone cells, osteoclasts, osteoblasts, osteocytes, bone resorption, bone formation, bone homeostasis, osteocyte apoptosis, osteoporosis, calcitonin, estrogen, growth factors, cytokines, mechanosensing, intercellular communication
- MeSH terms
- Animals, Bone and Bones, Calcification, Physiologic, Cell Communication, Humans, Models, Biological, Osteoblasts, Osteoclasts, Structure-Activity Relationship, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.